Company Monitoring Page for Bluebird-Bio

latest headlines for company on cafepharma

This Could Be the Next Big Pharma Buyout
Motley Fool
Sun, 04/3/16 - 10:56 am
Tags:
Big Pharma, M&A, JNJ, Geron, Acadia, Jazz Pharmaceuticals, Bluebird Bio, Kite Pharma
Bluebird Bio Up As Gene Therapy Scores Against Rare Disease
Investors.com
Sat, 03/5/16 - 09:44 am
Tags:
Bluebird Bio, gene therapy, Lenti-D, cerebral adrenoleukodystrophy
Celgene hitches wagon to Bluebird, doles out $10M as biotech launches 1st CAR-T trial
BioPharma Dive
Sun, 02/21/16 - 11:36 am
Tags:
Celgene, Bluebird Bio, CAR-BMCA, CAR-T
Here's Why Bluebird Bio Turned in a Disappointing 2015
Motley Fool
Sat, 01/9/16 - 10:40 am
Tags:
Bluebird Bio, LentiGlobin BB305
2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
TheStreet.com
Thu, 01/7/16 - 01:02 pm
Tags:
biotech, Celgene, biosimilars, Isis Pharmaceuticals, CAR-T, Bluebird Bio, Puma Biotechnology, MannKind
10 Biotechs Short Sellers Are Betting Against
Yahoo/Benzinga
Wed, 12/30/15 - 10:40 am
Tags:
biotech, Global Blood Therapeutics, Clovis Oncology, Epizyme, Bluebird Bio, Puma Biotechnology, Tokai, MannKind, Myriad Genetics, Orexigan, KaloBios
4 Top Biotech Stocks for 2016
24/7 Wall St
Fri, 12/18/15 - 08:57 am
Tags:
Roche, Amgen, Bluebird Bio, Valeant Pharmaceuticals
5 Key BioPharma Movers That Cannot Be Ignored
24/7 Wall St
Sun, 12/13/15 - 10:57 am
Tags:
IMO-8400, Idera Pharmaceuticals, pracinostat, MEI Pharma, Bluebird Bio, CAR-T, Cara Therapeutics, CR845, TherapeuticsMD, TX-004HR
Bluebird Bio: Another Look At The Company After The 2015 ASH Meeting
Seeking Alpha
Fri, 12/11/15 - 10:28 pm
Tags:
Bluebird Bio
Bluebird Sickle Cell Gene Therapy Falls Short of High Expectations
TheStreet.com
Sun, 12/6/15 - 11:04 am
Tags:
Bluebird Bio, sickle cell disease, gene therapy, LentiGlobin
Bluebird, Celgene See Promise in T Cell Therapy for Multiple Myeloma
TheStreet.com
Sat, 12/5/15 - 12:37 pm
Tags:
Bluebird Bio, Celgene, t cell therapy, Multiple Myeloma
Bluebird Bio's Best Bet Is To Tackle Sickle Cell Disease
Forbes
Thu, 11/19/15 - 01:16 pm
Tags:
Bluebird Bio, sickle cell disease
Bluebird Bio Selling 'An Overreaction,' Data Is 'Fantastic' Says Biotech Expert
Yahoo/Benzinga
Thu, 11/5/15 - 08:57 pm
Tags:
Bluebird Bio
Bluebird Shares Plunge on Waning Effect of Old Gene Therapy
TheStreet.com
Mon, 10/19/15 - 05:43 pm
Tags:
Bluebird Bio, gene therapy, beta-thalassemia
Which Big Pharma Will Grab the Lion’s Share of the Cancer Immunotherapy Market?
Motley Fool
Wed, 09/30/15 - 07:59 pm
Tags:
cancer immunotherapy, Juno Therapeutics, Kite Pharma, Celgene, Bluebird Bio, AstraZeneca, Pfizer, Bristol-Myers Squibb
3 Clinical Trials to Watch As Bluebird Bio Rounds Out 2015
Motley Fool
Mon, 09/14/15 - 08:28 am
Tags:
clinical trials, Bluebird Bio, HGB-205, HGB-206, HGB-204, sickle cell disease, beta-thalassemia
Seattle Children's teams up with Juno competitor on gene editing research
Bizjournals.com
Fri, 09/11/15 - 05:49 pm
Tags:
Seattle Genetics, Juno Therapeutics, Bluebird Bio, gene editing
3 Biotech Stocks That Could Be Buyout Targetst
Motley Fool
Fri, 08/21/15 - 09:46 am
Tags:
Intrexon, Ziopharm, Bluebird Bio, Biomarin
Bluebird Falls as Operating Costs Soar Amid Biotech Selloff
Bloomberg
Fri, 08/7/15 - 06:04 pm
Tags:
Bluebird Bio, earnings
What's in bluebird bio's Pipeline That Has Investors So Excited?
Motley Fool
Sun, 07/19/15 - 05:35 pm
Tags:
Bluebird Bio, gene therapy, LentiGlobin, beta-thalassemia, sickle cell disease

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.